Raymond James Financial’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Raymond James Financial's WST Position: Q3 2026 in Review
Raymond James Financial reduced its West Pharmaceutical (WST) stake by 13% in Q3 2026, selling an estimated $4.08M and leaving 80,516 shares worth $29.9M. The position accounts for 0.01% of the portfolio, ranked #1252.
Raymond James Financial first reported a position in WST in Q4 2024 and has held it in 8 quarters since. The position peaked at $72.6M in Q4 2024. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Raymond James Financial held 80,516 shares of West Pharmaceutical worth $29.9M as of Q3 2026.
- Raymond James Financial sold 11,556 West Pharmaceutical shares in Q3 2026, an estimated $4.08M.
- West Pharmaceutical made up 0.01% of Raymond James Financial's portfolio in Q3 2026, its #1252 holding.
- Raymond James Financial first reported a position in West Pharmaceutical in Q4 2024 and has held it in 8 quarters since.
- Raymond James Financial's West Pharmaceutical position peaked at $72.6M in Q4 2024.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.